BALDARI COSIMA | Elenco docenti

Lopresti, L., Capitani, N., Tatangelo, V., Tangredi, C., Boncompagni, G., Frezzato, F., et al. (2024). p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1297116]. - dettaglio
Zevolini, F., Onnis, A., Khazen, R., Müller, S., Marotta, G., Valitutti, S., et al. (2024). Polo-like kinase 1 regulates immune synapse assembly and cytotoxic T cell function by driving microtubule dynamics. JOURNAL OF CELL SCIENCE, 137(5) [10.1242/jcs.261476]. - dettaglio
Rossi, S., Tatangelo, V., Dichiara, M., Butini, S., Gemma, S., Brogi, S., et al. (2024). A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients. BIOMÉDECINE & PHARMACOTHÉRAPIE, 174 [10.1016/j.biopha.2024.116537]. - dettaglio
Boncompagni, G., Tatangelo, V., Lopresti, L., Ulivieri, C., Capitani, N., Tangredi, C., et al. (2024). Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. CELL DEATH & DISEASE, 15(2) [10.1038/s41419-024-06528-6]. - dettaglio
Montecchi, T., Nannini, G., De Tommaso, D., Cassioli, C., Coppola, F., Ringressi, M.N., et al. (2024). Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression. CANCER IMMUNOLOGY, IMMUNOTHERAPY, 73(1), 2-12 [10.1007/s00262-023-03614-0]. - dettaglio